Search Results - "Bolinger, Andrew A"
-
1
Exploring New Vista for Alzheimer's Disease Drug Targets (Part II)
Published in Current topics in medicinal chemistry (01-01-2023)Get more information
Journal Article -
2
Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023
Published in Current topics in medicinal chemistry (01-01-2024)“…Fluorine continues to show its potential applications in drug discovery and development, as reflected by twelve drugs being fluorinated out of the fifty-five…”
Get more information
Journal Article -
3
RIPTACs: A groundbreaking approach to drug discovery
Published in Drug discovery today (01-11-2023)“…•A groundbreaking drug discovery approach using regulated induced proximity targeting chimeras (RIPTACs) is introduced.•Proof-of-concept and preliminary…”
Get full text
Journal Article -
4
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2)
Published in Journal of medicinal chemistry (24-08-2023)“…Nuclear receptor binding SET domain proteins (NSDs) catalyze the mono- or dimethylation of histone 3 lysine 36 (H3K36me1 and H3K36me2), using…”
Get full text
Journal Article -
5
Novel approaches to targeted protein degradation technologies in drug discovery
Published in Expert opinion on drug discovery (03-04-2023)“…Target protein degradation (TPD) provides a novel therapeutic modality, other than inhibition, through the direct depletion of target proteins. Two primary…”
Get more information
Journal Article -
6
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics
Published in Expert opinion on therapeutic targets (2023)“…Inflammatory bowel diseases (IBDs) are debilitating chronic inflammatory disorders with increasing prevalence worldwide. Epigenetic regulator…”
Get more information
Journal Article -
7
Therapeutic potential of salicylamide derivatives for combating viral infections
Published in Medicinal research reviews (01-07-2023)“…Since time immemorial human beings have constantly been fighting against viral infections. The ongoing and devastating coronavirus disease 2019 pandemic…”
Get full text
Journal Article -
8
Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases
Published in Inflammatory bowel diseases (15-11-2021)“…Abstract Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a class of severe and chronic diseases of the…”
Get full text
Journal Article -
9
Design, synthesis, and pharmacological evaluations of pyrrolo[1,2-a]quinoxaline-based derivatives as potent and selective sirt6 activators
Published in European journal of medicinal chemistry (15-01-2023)“…Sirt6 activation has emerged as a promising drug target for the treatment of various human diseases, while only limited Sirt6 activators have been reported…”
Get full text
Journal Article -
10
Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target
Published in ACS chemical neuroscience (20-09-2023)“…G protein-coupled receptors (GPCRs) are successful druggable targets, making up around 35% of all FDA-approved medications. However, a large number of…”
Get full text
Journal Article -
11
Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5‑HT2C Receptor and Dual 5‑HT2C/5-HT2A Receptor Modulators
Published in Journal of medicinal chemistry (27-07-2023)“…The serotonin 5-HT2A receptor (5-HT2AR) and 5-HT2CR localize to the brain and share overlapping signal transduction facets that contribute to their roles in…”
Get full text
Journal Article -
12
Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT 2C Receptor and Dual 5-HT 2C /5-HT 2A Receptor Modulators
Published in Journal of medicinal chemistry (27-07-2023)“…The serotonin 5-HT receptor (5-HT R) and 5-HT R localize to the brain and share overlapping signal transduction facets that contribute to their roles in…”
Get full text
Journal Article